Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 545.4	$ 378.1
Accounts receivable, less allowance for credit losses	1,278.5	1,259.6
Inventories	2,128.6	2,148.0
Prepaid taxes	234.6	326.7
Prepaid expenses and other current assets	347.3	271.0
Current assets of discontinued operations		501.6
Total Current Assets	4,534.4	4,885.0
Property, plant and equipment, net	1,801.6	1,836.6
Goodwill	8,798.8	8,919.4
Intangible assets, net	5,136.5	5,533.6
Other assets	1,062.0	1,005.0
Noncurrent assets of discontinued operations		1,276.8
Total Assets	21,333.3	23,456.4
Current Liabilities:
Accounts payable	333.9	306.5
Income taxes payable	30.4	62.0
Customer rebates	115.9	129.5
Other current liabilities	1,156.4	1,187.6
Current portion of long-term debt	659.1	1,605.1
Current liabilities of discontinued operations		177.2
Total Current Liabilities	2,295.7	3,467.9
Deferred income taxes, net	541.3	558.5
Long-term income tax payable	581.3	583.0
Other long-term liabilities	608.7	548.5
Long-term debt	5,055.2	5,463.7
Noncurrent liabilities of discontinued operations		168.4
Total Liabilities	9,082.2	10,790.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 313.6 million shares in 2022 (312.8 million in 2021) issued	3.1	3.1
Paid-in capital	9,463.9	9,314.8
Retained earnings	9,739.9	10,292.2
Accumulated other comprehensive loss	(244.9)	(231.6)
Treasury stock, 103.8 million shares in 2022 and 2021	(6,717.3)	(6,717.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,244.7	12,660.7
Noncontrolling interest	6.4	5.7
Total Stockholders' Equity	12,251.1	12,666.4
Total Liabilities and Stockholders' Equity	$ 21,333.3	$ 23,456.4